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Abstract. Stroke to this day is still a disease that causes a high disability. In the future, it will require a prohibitive cost so 
that it has an impact on the socio-economic consequences for patients and their families. The price is prohibitive so that 
the impact on socioeconomic implications for patients and their families. Because of that, the purpose of the study is to 
estimate the cause of the cost that causes an economic burden from a stroke. The method that is used is a content analysis 
by doing a further literature review from various sources, from journal to textbook from a national level to international. 
Literature studies show that direct medical cost, which is rehabilitation, and nursing care cost is identified as the leading 
contributor to the high price of economic burden from a stroke. High costs incurred cause family to experience 
catastrophic financial disaster; it even impacts to drop welfare level. Social preventive action is needed to reduce the high 
prevalence of stroke to reduce the cost, to protect every household from financial disaster from a stroke. 
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INTRODUCTION 
Stroke clinical signs develop rapidly from focal (or 
global) disturbance of the cerebral function with 
symptoms that lasted for 24 hours or more even can 
lead to death, without apparent cause apart from a 
vascular origin (1). Stroke causes sudden death of several 
brain cells due to the lack of oxygen. When the 
bloodstream going to the brain is gone or reduced by 
the presence of clogging or rupture in the blood vessel 
from the artery to the brain (1). A Stroke happens 
because the blood flow to the brain is disturbed so that 
without oxygen-rich blood, brain cells will die. Stroke 
is the leading cause of long-term disability and 
preventable disability. Stroke or vascular dementia is 
the leading cause of memory loss (2). 
 
The risk factor of stroke is similar to coronary heart 
disease and other vascular diseases, which are 
unhealthy lifestyles like smoking, low physical level of 
exercise, unhealthy diet, and obesity (2,3). Other diseases 
that can become a risk factor are hypertension, 
hyperlipidemia, and diabetes (3). 
Cerebrovascular disease(stroke) is the second leading 
cause of death and the third leading cause of disability 
in the world (3). In the united states of America, every 4 
minutes someone dies because of stroke (2). In Qatar, 
cardiovascular disease cause 15% of all death (4). In sub-
Saharan Africa, where it is going through an 
epidemiology transition, stroke, and other vascular 
diseases contribute even more to the morbidity of the 
disease (6). Stroke is also the leading cause of dementia 
and depression (3). 
In Indonesia, stroke is the leading cause of death for 
people age above five years old, which is around 15,4% 
of all death (7). Based on the data from Riset Kesehatan 
Dasar (Riskesdas) in the year 2018, the prevalence of 
stroke is 10,9 for every 1.000 citizens. This number is 
increasing compared to the result of Riskesdas 2013, 
which is 7 for every 1.000 citizens. Stroke has become 
the leading cause of death in almost all hospitals in 
Indonesia, which is around 15,4% (8,9). 
Stroke has significant mortality, morbidity, and social-
economic consequence for the patients, their partner, 
and society (10). In South Africa, stroke is a disease with 
a high economic burden (7). Stroke is a significant 
economic burden for the resident of turkey (11). As an 
illustration, the highest overall cost (outpatient/inpatient 
care) reported in the USA (average cost 4.644$ for a 
patient every one month), followed by Denmark, 
Hollan, and Norway. The service utilization component 
in which rehabilitation and care are identified as a 
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is by no means limited to western or high-income 
countries (18). About 85% of all deaths from stroke are 
recorded in low and middle-income countries, which 
also accounts for 87% of total losses due to stroke 
(DALY) accounting for 72 million per year worldwide 
(18). Stroke burden is disproportionately higher in China, 
Africa, and South America, while the burden of IHD 
(Ischemic Heart Disease) is higher in the Middle East, 
North America, Australia and most of Europe. Lower 
national income is associated with relatively higher 
mortality and disease burden due to stroke (19). 
The global burden of stroke is high, including increased 
incidence, mortality, DALY, and economic impacts, 
especially in low and middle-income countries (20). 
Population growth and aging play an essential role in 
the increase of observed stroke loads (16). 
A better implementation of surveillance systems and 
prevention programs is needed to help track current 
trends and to inhibit the projected exponential increase 
in stroke worldwide (20). A Global mapping is an 
important method and tool for visualizing stroke loads 
and trends in various regions and countries (16). 
In Indonesia, based on data from Riset Kesehatan Dasar 
(Riskesdas) in 2018, the prevalence of stroke is 10.9 per 
1,000 population. This is an increase when compared to 
the results of Riskesdas 2013, which amounted to 7.0 
per 1000 population (8.9). 
The Economic Burden of Stroke 
Although this study is not using a complete economic 
evaluation technique, it can be used to provide 
information and identify the costs incurred by disease 
using the study of the cost of illness. The costs 
calculated in the cost of illness are: 
a) Direct Cost, which is the costs that exist in the 
health care system, community, patients, and 
families directly related to the illness. 
b) Indirect Cost, i.e. loss of productivity due to 
illness, costs incurred by the patient, the 
community, or the patient's family or 
employer. 
Intangible Cost, which is costs that cannot or are 
difficult to calculate or quantify, which usually consists 
of pain, sadness/sorrow, and suffering and loss of 
leisure time due to illness. 
In addition to being a burden on the country, a series of 
treatments, therapy, and rehabilitation therapies 
undertaken by stroke patients also pose a significant 
economic burden to the patient and the patient's family. 
Stroke is a big challenge for patients and their families, 
the number of direct costs that must be incurred for 
acute care and rehabilitation and indirect costs due to 
lost productivity of patients and their families is also a 
significant burden for the health care system (13). 
Despite improvements in the prevention of primary and 
secondary cardiovascular disease, acute ischemic stroke 
remained a significant burden on the high-volume 
health care system at visits and increased care costs (14). 
For this reason, researchers try to conduct a literature 
study to determine the economic burden borne by 
patients and families caused by stroke. 
METHOD  
This journal IS using literature study 
techniques/literature review to obtain information 
related to stroke health problems including the 
magnitude of the problem of stroke and the economic 
burden bore by patients and families caused by stroke. 
Information was taken from various data sources, 
including the results of the 2013 and 2018 Survey 
Kesehatan Dasar (Riskesdas), the results of studies 
conducted by the Ministry of Health, previous studies 
on the topic of stroke especially the burden of stroke 
and the economic burden of stroke, and the rules and 
policies related to social security. 
 
RESULT AND DISCUSSION 
The Magnitude of the Stroke Problem 
Worldwide, stroke is the second leading cause of death 
and the third leading cause of disability (DALY) (15). 
Also, the global burden of stroke increased between 
1990 and 2010, the number of stroke-related deaths 
increased by 26%, and DALY or record due to stroke 
also increased by 19% (15). Globally, 90.5% of the 
stroke burden (measured in DALY) is caused by 
modifiable risk factors such as unhealthy living 
behaviors (16). 
Until four decades ago, the incidence of stroke in low 
and middle-income countries was much lower than in 
economically stronger countries (17). However, in the 
following years, the incidence of strokes in places like 
southern India and rural South Africa was about two 
times higher compared to before, while the rate of 
strokes in economically more developed countries 
decreased (17). The level of disability and death from 
stroke is ten times greater in countries that are 
medically under-served compared to developed 
countries (17). 
Stroke is a global epidemic, and the problem of stroke 
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The literature review revealed that the majority of cost-
related analyzes focused on short-term care in hospital 
and acute care as the main drivers of stroke inpatient 
costs (13,21,22). Also, long-term medical costs resulting 
from rehabilitation and outpatient care as well as 
indirect expenses from lost income and informal 
expenses are the most significant burden on lifetime 
stroke costs (12). Further research focusing on long-term 
and indirect expenditure is critical to assess the impact 
of new treatments on the total cost of stroke. Overall, 
the high costs associated with stroke indicate there is a 
vital need for effective preventive therapy, acute care, 
and rehabilitation, which in turn will reduce national 
spending on health services related to stroke and 
increase productivity (21). 
 
Coping strategy 
In response to a sick family member, another 
household member will decide to seek treatment (23). If 
the disease is severe, household members will sacrifice 
their work time to maintain the family and seek 
expenses for the treatment of sick families (23). Coping 
strategy is an action that aims to regulate the cost of an 
event or process (for example, sick), which will 
threaten the welfare of one or more household 
members. In the end, the coping strategy seeks to 
maintain economic viability and household 
sustainability (23). 
Several studies have identified household coping 
strategies in dealing with a disease, such as taking a 
loan, selling assets, and even preventing costs that 
would arise by ignoring the disease / not doing a 
treatment. Two critical factors for household success in 
overcoming the costs of falling ill are the ability of 
households to overcome shocks (shock) with wealth 
(assets) owned in the form of physical capital, finance, 
education, and community resources. Secondly, the 
ability to cope is greatly influenced by the type, 
severity, and duration of the disease itself, and this is 
related to the use of different resources for each disease 
trait (23). 
The loss of workdays and the decline in household 
welfare due to stroke makes the patient or family 
coping strategy by taking a loan from the bank, selling 
assets, or doing both. Coping Strategy is an action that 
aims to regulate costs such as illness, which will 
threaten the welfare of one or more household members 
(23). The burden of disease due to stroke plus 
households conducting coping strategies will worsen 




Catastrophic financial disasters are direct payments 
from personal pockets (Out of Pocket) that exceed 10% 
of total household income (23). Expenditures from 
personal pockets (out of pocket) for health are any 
direct expenditure by households including gratuities in 
the form of payment for consulting services, medicines, 
therapeutic equipment, and other goods/services that 
contribute to improving health status. This definition 
can include transportation costs for accessing health 
services and medicines at pharmacies, and 
consumables, but does not include taxes related to 
health or insurance (16). 
Studies on the analysis of stroke costs show out of 
pocket costs incurred due to stroke is $ 103,576 on 
average in all stroke subtypes, with acute care costs 
incurred within 2 years after the first stroke accounted 
for 45.0%, long-term outpatient care length accounted 
for 35.0%, and rehabilitation costs accounted for 17.5% 
of the total lifetime cost of a stroke (24). Meanwhile, in 
Indonesia, the total cost of a stroke that must be 
incurred by patients is Rp. 643,783,379.40. The 
average cost in the first episode of a stroke inpatient is 
Rp. 13,826,124,54 ± Rp. 8,627,671.85 and the first 
episode of outpatient Rp. 600,215.97, - ± Rp. 
365,042,33. (13) 
The choice of stroke calculation from the perspective of 
the patient is used because the economic burden bore 
by stroke patients and household members are quite 
high, not only the direct costs associated with the health 
care system but also the impact of health care 
interventions in the broader family economy, 
specifically, in reducing costs for work absenteeism 
due to illness (25). Even households often fall into 
poverty because they finance health services (26).  
People who suffer a stroke cannot work, which affects 
productivity. Other household members are affected, 
not only to help support the family's economy but also 
to pay medical expenses for patients and for health 
services whose value is very significant. Caring for 
stroke patients puts social, emotional, health, and 
financial pressure on informal caregivers (family 
members). These burdens and tensions increase with 
the duration of a stroke, intimacy, the small number of 
caregivers, and the length of caregiving every day (22). 
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The economic burden will be more severe if households 
do not have health insurance and make cash payments 
for stroke treatment. With limited resources, 
households would sell assets or take debt for the cost of 
stroke treatment, causing households to experience 
catastrophic and decrease the level of welfare.  
CONCLUSION 
Literature studies show that direct medical costs in the 
form of rehabilitation costs and nursing care are 
identified as the main contributors that cause the high 
economic burden bore by patients and families due to 
stroke. The high out of pocket costs incurred caused 
families experiencing catastrophic financial disasters. 
Meanwhile, coping strategies carried out by patients' 
families due to the high economic burden due to stroke 
caused patients and families to experience long-term 
financial threats that result in a decrease in family 
welfare. 
SUGGESTION 
Social preventive measures are needed to reduce the 
magnitude of the prevalence of stroke in order to 
reduce the burden of costs, in order to protect every 
household from the financial threat due to stroke. This 
result is also useful for determining policies in the 
health sector, for health planning and budgeting. An 
example is the number of costs incurred/needed by the 
government annually incurred in the benefits of health 
insurance for the treatment of patients suffering from a 
stroke.  
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The total value obtained from the IFE matrix is 2.06, 
and the EFE matrix is 2.95. So based on the IE matrix 
is in quadrant V which is Hold and Maintain (maintain 
and maintain), the recommended strategies are Market 
Penetration and Product Development. 
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